Koza Altin Isletmeleri A.S. (IST:KOZAL)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions TRY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 12, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	74,985	72,296	62,535	86,162	17,644	14,747
Market Cap Growth	14.33%	15.61%	-27.42%	388.33%	19.65%	28.48%
Enterprise Value	61,046	60,699	52,974	76,313	10,075	9,203
Last Close Price	23.42	22.58	19.53	26.51	4.92	4.11
PE Ratio	55.03	119.70	106.66	-	5.87	8.15
Forward PE	25.37	0.34	9.82	16.45	7.01	6.91
PS Ratio	8.42	8.28	5.34	7.69	4.41	4.54
PB Ratio	2.27	2.44	2.10	3.70	1.67	1.95
P/TBV Ratio	2.27	2.45	2.11	3.72	1.67	1.95
P/FCF Ratio	-	-	-	29.70	8.29	14.62
P/OCF Ratio	36.12	23.16	-	22.22	6.74	11.27
PEG Ratio	-	0.12	0.12	0.12	0.12	0.12
EV/Sales Ratio	6.85	6.95	4.53	6.81	2.52	2.83
EV/EBITDA Ratio	56.90	43.03	24.37	14.82	5.04	4.81
EV/EBIT Ratio	-	368.89	44.50	18.14	5.60	5.41
EV/FCF Ratio	-25.15	-	-	26.31	4.73	9.13
Debt / Equity Ratio	0	0	0.02	0.00	0.01	0.00
Debt / EBITDA Ratio	0.00	0.00	0.26	0.01	0.02	0.01
Debt / FCF Ratio	-	-	-	0.02	0.02	0.01
Asset Turnover	0.26	0.27	0.39	0.59	0.39	0.44
Inventory Turnover	3.35	2.43	4.17	5.58	3.62	2.95
Quick Ratio	6.79	6.34	5.34	9.36	7.99	9.69
Current Ratio	8.17	8.14	6.24	10.32	8.40	10.43
Return on Equity (ROE)	8.52%	2.04%	2.21%	-19.53%	33.14%	27.18%
Return on Assets (ROA)	1.60%	0.31%	2.50%	13.78%	10.98%	14.44%
Return on Capital (ROIC)	1.77%	0.34%	2.77%	15.49%	12.36%	15.95%
Return on Capital Employed (ROCE)	2.30%	0.50%	3.90%	17.30%	16.40%	21.90%
Earnings Yield	1.82%	0.83%	0.94%	-3.84%	17.03%	12.28%
FCF Yield	-3.24%	-1.74%	-5.48%	3.37%	12.06%	6.84%
Payout Ratio	-	-	390.16%	-	-	-
Buyback Yield / Dilution	0.00%	0.01%	0.01%	-	-	-

Updated Mar 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.